| Authors: |
Tan CR; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gordan L; Florida Cancer Specialists & Research Institute, Tampa, FL, USA., Richter J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., DiLeo R; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Mewawalla P; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Larson S; Department of Medicine, Hematology/Oncology, UCLA Health, Los Angeles, CA, USA., Davies F; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Oveisi D; Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Gupta-Werner N; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Medhekar R; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Yin X; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Cortoos A; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Armoon M; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Thompson-Leduc P; Analysis Group ULC, Montreal, QC, Canada., Rahman A; Analysis Group ULC, Montreal, QC, Canada., Tardif-Samson A; Analysis Group ULC, Montreal, QC, Canada., Vanden Eynde C; Analysis Group ULC, Montreal, QC, Canada., Reitan J; RJM Group LLC, Crown Point, IN, USA., Milkovich G; RJM Group LLC, Crown Point, IN, USA., Bubalo J; Pharmacy Services, Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA., Forman A; Ascension Providence Hospital, Southfield, MI, USA., Bryan B; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Sborov D; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Kaila S; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. |
